Literature DB >> 15685504

Insulin resistance in patients with chronic kidney disease.

Shuzo Kobayashi1, Kyoko Maesato, Hidekazu Moriya, Takayasu Ohtake, Toshio Ikeda.   

Abstract

BACKGROUND: It has been reported that insulin resistance appears at an earlier stage of chronic kidney disease (CKD). However, few data are available concerning what factors of metabolic abnormalities, such as apolipoprotein (Apo) profile or acidosis, might be associated with insulin resistance in patients with CKD.
METHODS: We used the hyperinsulinemic euglycemic glucose clamp technique to examine insulin sensitivity in patients without diabetes (n = 29) with different stages of renal function. Results were compared with those in healthy subjects (n = 10) and related to various affecting variables.
RESULTS: In healthy subjects, the glucose disposal rate (GDR) was 9.93 +/- 1.33 mg/kg/min. The GDR of patients with CKD (6.91 +/- 2.46 mg/kg/min) was significantly less than that of healthy subjects ( P < 0.01), which shows diminished insulin sensitivity in patients with CKD. There was a negative correlation between GDR and serum creatinine level ( r = -0.449; P < 0.05) and positive correlations between GDR and creatinine clearance ( r = 0.549; P < 0.01) and Apo A-1/B levels ( r = 0.396; P < 0.05). Of particular relevance is the observed close correlation between GDR and bicarbonate level, with an extremely high predictive value for degree of acidosis ( r = 0.611; P < 0.0005). Stepwise multivariate regression analysis selected bicarbonate (F = 13.28) and Apo A-1/B levels (F = 6.58) as independent contributing variables.
CONCLUSION: We found that insulin resistance correlated linearly with decline in renal function. Independent variables related to insulin resistance were bicarbonate and Apo A-1/B levels in patients with CKD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685504     DOI: 10.1053/j.ajkd.2004.09.034

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  76 in total

Review 1.  Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism?

Authors:  Mohammed Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2010-12-03       Impact factor: 5.992

Review 2.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

3.  Insulin resistance, microalbuminuria, and chronic kidney disease.

Authors:  Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

4.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 5.  Measurement of insulin resistance in chronic kidney disease.

Authors:  Hien Pham; Kristina M Utzschneider; Ian H de Boer
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-11       Impact factor: 2.894

Review 6.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

7.  Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.

Authors:  Hong Xu; Xiaoyan Huang; Johan Arnlöv; Tommy Cederholm; Peter Stenvinkel; Bengt Lindholm; Ulf Risérus; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-16       Impact factor: 8.237

8.  Coronary artery calcification, ADMA, and insulin resistance in CKD patients.

Authors:  Shuzo Kobayashi; Machiko Oka; Kyoko Maesato; Ryota Ikee; Tsutomu Mano; Moriya Hidekazu; Takayasu Ohtake
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 8.237

9.  Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis.

Authors:  Leszek Niepolski; Alicja E Grzegorzewska; Monika Młot-Michalska
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

10.  Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.

Authors:  Eugene Sobngwi; Sostanie Enoru; Gloria Ashuntantang; Marcel Azabji-Kenfack; Mesmin Dehayem; Arnold Onana; Daniel Biwole; François Kaze; Jean-François Gautier; Jean-Claude Mbanya
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.